Form 4: Genasys Inc. CEO Richard Danforth Granted 450,000 Employee Stock Options
SEC Form 4 Filing
Genasys Inc. CEO Richard Danforth received a grant of 450,000 employee stock options on August 19, 2024, as reported in a Form 4 filing with the SEC.
Summary
- Richard Danforth, CEO of Genasys Inc., was granted 450,000 employee stock options on August 19, 2024.
- The exercise price of these options is $2.70.
- The options expire on August 19, 2031.
- The options vest in three equal installments: 1/3 on September 30, 2024, 1/3 on September 30, 2025, and 1/3 on September 30, 2026.
- Following the transaction, Danforth directly owns 450,000 derivative securities.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests. The vesting schedule suggests a long-term commitment.
Positives
- The grant of stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including stock options, vary significantly across industries and company sizes.
- Comparing the size and vesting schedule of these options to those of CEOs at similarly sized technology companies would provide a better benchmark.
- Companies like Digital Ally and Federal Signal are competitors in the broader safety and security technology space, and their executive compensation structures could offer relevant comparisons.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CEO to drive long-term value.
- Employees may see the grant as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Date of earliest transaction: Grant of employee stock options. |
| 08/19/2024 | Grant date of the option to purchase 450,000 shares. |
| 08/19/2031 | Expiration date of the employee stock options. |
| 09/30/2024 | First vesting date for 1/3 of the shares. |
| 09/30/2025 | Second vesting date for 1/3 of the shares. |
| 09/30/2026 | Third vesting date for 1/3 of the shares. |
| 08/21/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.